TYRO3 and breast cancer: Phosphorylation of TYRO3 has been demonstrated in melanoma [49,51,52], breast cancer [37], and leiomyosarcoma [61] cell lines and in chronic lymphocytic leukemia [69] and schwannoma [55] patient samples.